Scientists map metabolic shifts in skin cancer development
NCT ID NCT04389112
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined 119 people with precancerous or early skin cancer lesions to understand how cells change as they become cancerous. Researchers took small skin samples and analyzed their metabolism and protein markers. The goal was to learn more about the transition from harmless spots to skin cancer, which could improve early detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify early warning signs of skin cancer, leading to better detection and prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. The findings may not directly lead to new tests or therapies, and results may not apply to all skin cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Saint-André - CHU de Bordeaux
Bordeaux, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy before surgery may cut skin cancer recurrence
- Cancer-Killing virus shows promise in early trial for advanced tumors
- New drug IDP-001 takes on advanced cancers in early trial
- New combo therapy aims to shrink inoperable skin cancers
- Tiny needle patch takes aim at skin cancer
- Pedaling against cancer: exercise may boost immunotherapy